RXST
Price
$5.28Alerts
Change
+$0.38 (+7.76%)
Updated
Nov 11 closing price
Capitalization
188.83M
111 days until earnings call
Intraday BUY SELL Signals
STE
Price
$256.27Alerts
Change
-$0.85 (-0.33%)
Updated
Nov 11 closing price
Capitalization
24.6B
90 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

RXST vs STE

RXST vs STE Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
RXST vs. STE commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RXST is a StrongBuy and STE is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for RXST with price predictions
Nov 11, 2026

RXST in upward trend: price rose above 50-day moving average on November 11, 2026

RXST moved above its 50-day moving average on November 11, 2026 date and that indicates a change from a downward trend to an upward trend. In 36 of 43 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 84%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where RXST's RSI Oscillator exited the oversold zone, 36 of 44 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 82%.

The Momentum Indicator moved above the 0 level on November 10, 2026. You may want to consider a long position or call options on RXST as a result. In 65 of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 72%.

The Moving Average Convergence Divergence (MACD) for RXST just turned positive on November 09, 2026. Looking at past instances where RXST's MACD turned positive, the stock continued to rise in 36 of 46 cases over the following month. The odds of a continued upward trend are 78%.

Following a +8.64% 3-day Advance, the price is estimated to grow further. Considering data from situations where RXST advanced for three days, in 236 of 298 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 50 of 61 cases where RXST's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 82%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RXST declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.

RXST broke above its upper Bollinger Band on November 11, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for RXST entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 22 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 23 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.717) is normal, around the industry mean (4.142). P/E Ratio (-3.982) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (1.749) is also within normal values, averaging (40.124).

The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating fairly steady price growth. RXST’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 95 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RXST’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for STE with price predictions
Nov 11, 2026

STE in upward trend: 10-day moving average moved above 50-day moving average on October 22, 2026

The 10-day moving average for STE crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 53%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on STE as a result. In 49 of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 52%.

STE moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +1.91% 3-day Advance, the price is estimated to grow further. Considering data from situations where STE advanced for three days, in 155 of 312 cases, the price rose further within the following month. The odds of a continued upward trend are 50%.

The Aroon Indicator entered an Uptrend today. In 98 of 200 cases where STE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 49%.

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where STE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 57%.

STE broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 40 (best 1 - 100 worst), indicating steady price growth. STE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 66 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 67 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. STE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron PE Growth Rating for this company is 71 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 80 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.413) is normal, around the industry mean (4.142). P/E Ratio (30.693) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (1.760) is also within normal values, averaging (11.253). Dividend Yield (0.011) settles around the average of (0.011) among similar stocks. P/S Ratio (3.423) is also within normal values, averaging (40.124).

FUNDAMENTALS RATINGS
STE: Fundamental Ratings
STE
OUTLOOK RATING
1..100
21
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
PROFIT vs RISK RATING
1..100
67
SMR RATING
1..100
66
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
71
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RXSTSTE
RSI
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
54%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
68%
Momentum
ODDS (%)
Bullish Trend 1 day ago
72%
Bullish Trend 3 days ago
52%
MACD
ODDS (%)
Bullish Trend 1 day ago
78%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
53%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
47%
Advances
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 2 days ago
50%
Declines
ODDS (%)
Bearish Trend 9 days ago
84%
Bearish Trend 16 days ago
57%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
64%
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
49%
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (RXST: $4.90 vs. STE: $257.12)
Brand notoriety: RXST and STE are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: RXST: 110% vs. STE: 108%
Market capitalization -- RXST: $188.83M vs. STE: $24.6B
RXST [@Medical/Nursing Services] is valued at $188.83M. STE’s [@Medical/Nursing Services] market capitalization is $24.6B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $190.22B. The average market capitalization across the [@Medical/Nursing Services] industry is $6.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RXST’s FA Score shows that 2 FA rating(s) are green while STE’s FA Score has 0 green FA rating(s).

  • RXST’s FA Score: 2 green, 3 red.
  • STE’s FA Score: 0 green, 5 red.
According to our system of comparison, RXST is a better buy in the long-term than STE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RXST’s TA Score shows that 5 TA indicator(s) are bullish while STE’s TA Score has 5 bullish TA indicator(s).

  • RXST’s TA Score: 5 bullish, 3 bearish.
  • STE’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, RXST is a better buy in the short-term than STE.

Price Growth

RXST (@Medical/Nursing Services) experienced а +6.75% price change this week, while STE (@Medical/Nursing Services) price change was +11.14% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.89%. For the same industry, the average monthly price growth was -4.69%, and the average quarterly price growth was -1.76%.

Reported Earning Dates

RXST is expected to report earnings on Mar 03, 2027.

STE is expected to report earnings on Feb 10, 2027.

Industries' Descriptions

@Medical/Nursing Services (-2.89% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

RXST and

Correlation & Price change

A.I.dvisor indicates that over the last year, RXST has been loosely correlated with GMED. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if RXST jumps, then GMED could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RXST
1D Price
Change %
RXST100%
+7.76%
GMED - RXST
39%
Loosely correlated
+0.21%
DCTH - RXST
35%
Loosely correlated
+8.31%
STE - RXST
32%
Poorly correlated
-0.33%
UFPT - RXST
32%
Poorly correlated
+0.00%
ESTA - RXST
31%
Poorly correlated
+5.15%
More

STE and

Correlation & Price change

A.I.dvisor indicates that over the last year, STE has been loosely correlated with SYK. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if STE jumps, then SYK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STE
1D Price
Change %
STE100%
-0.33%
SYK - STE
58%
Loosely correlated
-1.70%
MDT - STE
57%
Loosely correlated
+0.02%
LH - STE
50%
Loosely correlated
+0.36%
GEHC - STE
50%
Loosely correlated
-1.26%
DHR - STE
49%
Loosely correlated
-0.34%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SUN65.342.13
+3.37%
Sunoco LP
BMRC28.49-0.16
-0.56%
Bank of Marin Bancorp
DRD23.95-0.68
-2.76%
DRDGOLD Ltd
FFAI0.24-0.01
-5.36%
Faraday Future Intelligent Electric Inc.
NWGL2.34-0.19
-7.51%
CL Workshop Group Limited